Gary H Rabin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gary H Rabin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary H Rabin. Gary H Rabin is CEO & CFO in Ocata Therapeutics, Inc. ($ACTC).
Latest Insider Trading Transactions of Gary H Rabin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 09 2012 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Grant | A | 0.00 | 1,000,000 | 0 | 15,262,401 | 14.3 M to 15.3 M (+7.01 %) |
| Jun 19 2012 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 350,000 | 25,095 | 14,262,401 | 14.6 M to 14.3 M (-2.40 %) |
| Jun 19 2012 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.07 | 300,000 | 21,240 | 14,612,401 | 14.9 M to 14.6 M (-2.01 %) |
| Jun 19 2012 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.08 | 175,029 | 13,127 | 14,912,401 | 15.1 M to 14.9 M (-1.16 %) |
| Aug 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Option Exercise | A | 0.45 | 5,000,000 | 2,250,000 | 5,000,000 | |
| Aug 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Option Exercise | A | 0.30 | 5,000,000 | 1,500,000 | 5,000,000 | |
| Aug 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Option Exercise | A | 0.19 | 10,000,000 | 1,850,000 | 10,000,000 | |
| Aug 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Grant | A | 0.00 | 10,000,000 | 0 | 15,087,430 | 5.1 M to 15.1 M (+196.56 %) |
| Jun 03 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.20 | 750,000 | 150,525 | 5,087,430 | 5.8 M to 5.1 M (-12.85 %) |
| May 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.16 | 4,000 | 628 | 5,837,430 | 5.8 M to 5.8 M (-0.07 %) |
| May 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.16 | 781,755 | 128,208 | 5,841,430 | 6.6 M to 5.8 M (-11.80 %) |
| May 25 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Sell | S | 0.16 | 414,245 | 64,208 | 6,623,185 | 7 M to 6.6 M (-5.89 %) |
| Feb 08 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Option Exercise | A | 0.14 | 5,000,000 | 700,000 | 5,000,000 | |
| Feb 08 2011 | ACTC | Ocata Therapeutics ... | Rabin Gary H | CEO & CFO | Grant | A | 0.00 | 5,000,000 | 0 | 10,890,993 | 5.9 M to 10.9 M (+84.88 %) |
Page: 1